Clinical trials recruiting in Tsuchiura-shi, Japan

Phase breakdown

Conditions recruiting in Tsuchiura-shi, Japan

Recruiting trials in Tsuchiura-shi, Japan

• A Study of LY3971297 in Participants With Heart Failure
  NCT07547540 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
  NCT07037433 · Phase: Phase 3 · Ages: 45 Years to 99 Years · Sex: All (male and female)
• Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
  NCT07684144 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
  NCT06307652 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Tsuchiura-shi, Japan?

5 recruiting trials have at least one study site in Tsuchiura-shi, Japan.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.